CA979805A - Method for isolation of antithrombin from animal tissue material by adsorption on sulfated carbohydrate gel - Google Patents

Method for isolation of antithrombin from animal tissue material by adsorption on sulfated carbohydrate gel

Info

Publication number
CA979805A
CA979805A CA151,075A CA151075A CA979805A CA 979805 A CA979805 A CA 979805A CA 151075 A CA151075 A CA 151075A CA 979805 A CA979805 A CA 979805A
Authority
CA
Canada
Prior art keywords
antithrombin
adsorption
isolation
animal tissue
tissue material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA151,075A
Other languages
English (en)
Other versions
CA151075S (en
Inventor
Lars-Olof Andersson
Maggie Miller-Andersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phadia AB
Original Assignee
Kabi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi AB filed Critical Kabi AB
Application granted granted Critical
Publication of CA979805A publication Critical patent/CA979805A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA151,075A 1971-09-08 1972-09-06 Method for isolation of antithrombin from animal tissue material by adsorption on sulfated carbohydrate gel Expired CA979805A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7111350A SE392038B (sv) 1971-09-08 1971-09-08 Forfarande for isolering av antitrombin ur blod eller blodprodukter

Publications (1)

Publication Number Publication Date
CA979805A true CA979805A (en) 1975-12-16

Family

ID=20293800

Family Applications (1)

Application Number Title Priority Date Filing Date
CA151,075A Expired CA979805A (en) 1971-09-08 1972-09-06 Method for isolation of antithrombin from animal tissue material by adsorption on sulfated carbohydrate gel

Country Status (22)

Country Link
US (1) US3842061A (fr)
JP (1) JPS5545528B2 (fr)
AT (1) AT324549B (fr)
AU (1) AU461865B2 (fr)
BE (1) BE787284A (fr)
CA (1) CA979805A (fr)
CH (1) CH577829A5 (fr)
CS (1) CS172957B2 (fr)
DE (1) DE2243688C3 (fr)
DK (1) DK131128B (fr)
ES (1) ES406199A1 (fr)
FI (1) FI50583C (fr)
FR (1) FR2154483B1 (fr)
GB (1) GB1356229A (fr)
HU (1) HU165070B (fr)
IE (1) IE36670B1 (fr)
IL (1) IL39982A (fr)
NL (1) NL154118B (fr)
NO (1) NO135302C (fr)
PL (1) PL83490B1 (fr)
SE (1) SE392038B (fr)
ZA (1) ZA726024B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US4054557A (en) * 1974-05-15 1977-10-18 Ab Kabi Growth promoting polypeptides and preparation method
US4103685A (en) * 1976-01-05 1978-08-01 Lupien Paul J Method and apparatus for extravascular treatment of blood
NZ180199A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Method of testing for the presence of elevated plasma liprotein concentration
NZ187246A (en) * 1976-03-04 1980-05-27 New Zealand Dev Finance Hydrophilic hydroxy c2-c4 alkylated crosslinked regenerated cellulose
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
SE422081B (sv) * 1979-08-22 1982-02-15 Ird Biomaterial Ab Sett att pavisa proteolytiska enzymer
US4386025A (en) * 1980-09-30 1983-05-31 Cutter Laboratories, Inc. Method of preparing antithrombin
US4446314A (en) * 1980-09-30 1984-05-01 Cutter Laboratories, Inc. Fractionation of heparin
DE3038163A1 (de) * 1980-10-09 1982-05-06 Boehringer Mannheim Gmbh, 6800 Mannheim Thrombininhibitor, seine herstellung und verwendung
FR2527222A1 (fr) * 1982-05-19 1983-11-25 Christine Fougnot Procede de separation et de purification des proteases et des antiproteases de la coagulation sanguine, ainsi que du complexe protease/antiprotease
US4632981A (en) * 1982-07-30 1986-12-30 Genentech, Inc. Human antithrombin III
CA1221307A (fr) * 1982-12-02 1987-05-05 Nobutaka Tani Adsorbent en methode de preparation
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
AT379310B (de) * 1983-05-20 1985-12-27 Immuno Ag Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
AU571078B2 (en) * 1984-04-14 1988-03-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Purification of filamentous hemagglutinin
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3519011A1 (de) * 1985-05-25 1986-11-27 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines materials zur affinitaetschromatographie
US4656254A (en) * 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
US4749783A (en) * 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
CA1341379C (fr) 1988-04-28 2002-07-23 Welfide Corporation Antithrombine iii purifiee et leur methode de preparation
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6491965B1 (en) * 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US5989593A (en) * 1996-11-20 1999-11-23 Yoshitomi Pharmaceutical Industries, Ltd. Method for producing antithrombin-III, method for purifying it, and preparation containing it
AT405739B (de) 1997-09-19 1999-11-25 Immuno Ag Verfahren zur reinigung von antithrombin iii
US8563693B2 (en) * 2001-01-26 2013-10-22 Acceleration Biopharmaceuticals, Inc. Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III
ATE377657T1 (de) * 2001-01-26 2007-11-15 Gen Hospital Corp Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
JP4970260B2 (ja) 2004-08-20 2012-07-04 プロメティック バイオサイエンシズ，リミテッド 親和性クロマトグラフィーによるタンパク質の逐次的単離および精製スキーム

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE366760B (fr) * 1967-12-18 1974-05-06 J Sjoevall
DE1907738A1 (de) * 1969-02-15 1970-08-13 Bayer Ag Verfahren zur Abtrennung des Trypsin-Plasmin-Inhibitors vom Thrombin-Inhibitor in handelsueblichen Hirudinpraeparaten und in Hirudinrohpraeparaten

Also Published As

Publication number Publication date
US3842061A (en) 1974-10-15
NO135302C (fr) 1977-03-23
NO135302B (fr) 1976-12-13
ZA726024B (en) 1973-05-30
JPS4835017A (fr) 1973-05-23
DK131128C (fr) 1975-11-03
FR2154483B1 (fr) 1977-01-14
GB1356229A (en) 1974-06-12
FI50583B (fr) 1976-02-02
IE36670L (en) 1973-03-08
SU447876A3 (ru) 1974-10-25
SE392038B (sv) 1977-03-14
AT324549B (de) 1975-09-10
BE787284A (fr) 1972-12-01
JPS5545528B2 (fr) 1980-11-18
DE2243688C3 (de) 1984-05-10
FI50583C (fi) 1976-05-10
FR2154483A1 (fr) 1973-05-11
CS172957B2 (fr) 1977-01-28
NL154118B (nl) 1977-08-15
DE2243688A1 (de) 1973-03-22
AU461865B2 (en) 1975-06-05
CH577829A5 (fr) 1976-07-30
IE36670B1 (en) 1977-01-19
DK131128B (da) 1975-06-02
AU4637372A (en) 1974-03-14
IL39982A0 (en) 1972-09-28
NL7211953A (fr) 1973-03-12
ES406199A1 (es) 1975-07-01
IL39982A (en) 1974-11-29
DE2243688B2 (de) 1978-06-15
PL83490B1 (fr) 1975-12-31
HU165070B (fr) 1974-06-28

Similar Documents

Publication Publication Date Title
CA979805A (en) Method for isolation of antithrombin from animal tissue material by adsorption on sulfated carbohydrate gel
AU470394B2 (en) Streptococci diagnostic method
CA1012458A (en) Physiological buffer system
CA974958A (en) Apparatus for treatment of cellulose-containing material
CA987969A (en) Sonic stylizing apparatus
CA971166A (en) Method for manufacture of ketose sugars
AU474746B2 (en) Process for the preparation of thiazole-sulphenamides
AU477038B2 (en) Process for the preparation of alpha-6-deoxytetracyclines
AU471441B2 (en) Process for the preparation of 2-hydrazino-benzothiazoles
AU472802B2 (en) Process for the preparation of 3-nitro-4-amino-toluene
CA936476A (en) Apparatus for producing artificial echoes
CA895825A (en) Air treating gel
CA818607A (en) Method of producing lignin-reinforced rubber
CA891834A (en) Process for the treatment of tobacco
AU490584B2 (en) Method for treatment of depression
CA897082A (en) Process for the cultivation of hemolytic streptococci
CA966046A (en) Sterilising procedures
CA1014158A (en) Method for the synthesis of (+-)-glaziovine
CA994157A (en) Simulated bone
CA914663A (en) Process for the manufacture of halohydrins
CA906849A (en) Treatment of cellulose
AU465205B2 (en) Improved process for the preparation of glucoside derivatives of thiocolchicine
CA855993A (en) Process for the treatment of tobacco
CA902474A (en) Process and diagnostic composition
CA893251A (en) Diagnostic composition and process